WEE1 and neoplasm: The study by Chen et al (2014) shows that chemical inhibition of glycogen synthase kinase 3 (GSK3) reduces ERMS tumor growth and self-renewal, demonstrating the therapeutic potential for targeting protein kinases that play a role in the regulation of RMS tumor growth and self-renewal [15].